Keywords
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

11125 Search results.

DACAPO-II Study - Interhospitaltransport

- 5/9/17 - 6 forms, 7 itemgroups, 34 items, 1 language
Itemgroups: Interhospitaltransport, Besatzung waehrend des Transports, Qaulifikationen des Transportarztes?, Qualifikationen erster Rettungsassistent, Kommunikation und Dauer, Komplikationen waehrend des Transports, Wenn Transportmitelverzoegerung = ja, was war der Grund fuer die Verzoegerun
Das schwere akute Lungenversagen des Erwachsenen: Einfluss der Versorgungsqualität und individueller Patientenmerkmale auf die gesundheitsbezogene Lebensqualität bei Überlebenden (DACAPO) Surviving ARDS: the influence of quality of care and individual patient characteristics on health-related quality of life (DACAPO)

Externe Klinik

7 itemgroups, 96 items23

Studienzentrum

4 itemgroups, 44 items23

Verlegung vom Studienzentrum

1 itemgroup, 18 items23

Demographische Daten

1 itemgroup, 11 items23
1 other form meeting the search is available in the detailed view.

End of study LenaMain-Study - Trial End

- 3/17/16 - 1 form, 10 itemgroups, 94 items, 1 language
Itemgroups: End of study, Survival Status, Monthly control visit with response evaluation, Parameter of multiple myeloma, Vital signs, Laboratory:Protein electrophoresis, Laboratory:Hematology, Laboratory:serum chemistry, Quality of life, Hematotoxicity CTC
A randomised comparison of daily 25 mg versus 5 mg lenalidomide as maintenance therapy after high-dose therapy and autologous stem cell transplantation in patients with multiple myeloma. Protocol-Code: RV-MM-PI-280 EudraCT-Number: 2007-003945-33 Author: Claus Schreiber Review: Gerd Felder Approval of CRF: Prof. Dr. med. G. Kobbe (LKP) Release for MDM: Prof. Gattermann, Düsseldorf (26.1.2016) Principal Investigator „LenaMain“-Studie: Prof. Roland Fenk, Düsseldorf Coordinating center for clinical trial Medical faculty of University Hospital Heinrich-Heine-University Scientific Director: Herr Dr. J. Grebe Moorenstrasse 5 40225 Düsseldorf Tel.: +49 (0) 211-81-19701 Fax: +49 (0) 211-81-19702

End of study PETAL Study NCT00554164 - End of study

- 11/23/16 - 1 form, 4 itemgroups, 25 items, 2 languages
Itemgroups: Comorbidity, Discontinuation, Adverse event, Footer module
Positronen-Emissionstomographie-gesteuerte Therapie aggressiver Non-Hodgkin-Lymphome (PETAL-Studie) Universitätsklinikum Essen (UK Essen) EudraCT-Nummer: 2006-001641-33 NCT00554164

End of Study: End of Study Post-Study Period [DS_2] NCT01117584

- 2/4/17 - 1 form, 1 itemgroup, 5 items, 1 language
Itemgroup: General Information
NCT01117584 Astellas Phase 2b, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy, Safety and Tolerability of a 12- Week Treatment with ASP1941 in Combination with Metformin in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone.

Study Conclusion End of Study Ropinirole NCT00632736 - Study Conclusion End of Study

- 7/30/17 - 1 form, 2 itemgroups, 6 items, 1 language
Itemgroups: STUDY CONCLUSION, Pregnancy information
Study part: Study Conclusion End of Study.An Open-Label Extension phase 3 Study with REQUIP (ropinirole) CR for Subjects from Studies 101468/165, 101468/168 and 101468/169 Patient Level Data. Study ID:101468/248, Clinical Study ID: 101468/248.

TEST Study - ODM-Form

- 6/18/18 - 1 form, 2 itemgroups, 5 items, 1 language
Itemgroups: Lab Identification Log, Physical Examination
TEST Study

Nerventra Study Study drug dispensing and return

- 6/8/16 - 1 form, 3 itemgroups, 22 items, 1 language
Itemgroups: Demographic Information, Drug dispensed, Drug dispensing and return
Nerventra Study (Eudra CT 2007-003226-19) Study MS-LAQ-301: A multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study, to evaluate the safety, tolerability and efficacy of daily oral administration of laquinimod 0.6 mg in subjects with relapsing remitting multiple sclerosis (RRMS)

Sample Study - Prior or Concomitant Medications (ACRO)

- 10/11/17 - 11 forms, 3 itemgroups, 17 items, 4 languages
Itemgroups: Common, Non-study Medications Taken, Prior or Concomitant Medications
A sample trial to demonstrate the end-to-end application of the CDISC Standards and transformations from ADL

Adverse Event Form (ACRO)

3 itemgroups, 16 items24

Complaints related to smoking

1 itemgroup, 6 items24

Laboratory

2 itemgroups, 15 items24

TEST Study - ODM-Form

- 8/7/17 - 1 form, 1 itemgroup, 1 item, 1 language
Itemgroup: Default Itemgroup
TEST Study

On-Study - Metastatic Brain Cancer - On-Study Form - 2287553v3.0 - Metastatic Brain Cancer - On-Study Form

- 1/9/15 - 1 form, 10 itemgroups, 64 items, 1 language
Itemgroups: CRF Header, Brain: Form Administration, Non-CNS: Initial Disease Description, Brain: Current Disease Description, Brain: Concomitant Medications, Metastatic Brain: Prior Health History, Metastatic Brain: Prior Treatment, Brain: Prior Treatment - Systemic Regimens, Brain: Prior Treatment - CNS RT, Brain: Prior Treatment - CNS Surgery
Metastatic Brain Cancer - On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EF3A8ACE-5457-4C56-E034-0003BA3F9857

On-Study - Colorectal Cancer - Adjuvant On-Study Form - 2263800v3.0 - Colorectal Cancer - Adjuvant On-Study Form

- 1/9/15 - 1 form, 4 itemgroups, 18 items, 1 language
Itemgroups: CRF Header, Colorectal: Form Administration, Colorectal: Disease Characteristics, Comments
Colorectal Cancer - Adjuvant On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DB75551B-5D8C-2D1C-E034-0003BA12F5E7

On-Study - Waldenstroms Macroglobulinemia - On-Study Form - 2273908v3.0 - Waldenstroms Macroglobulinemia - On-Study Form

- 1/9/15 - 1 form, 5 itemgroups, 57 items, 1 language
Itemgroups: CRF Header, Waldenstrom's: Form Administration, Waldenstrom's: Disease Description, Waldenstrom's: Prior Treatment, Waldenstrom's: Relapsed Disease
Waldenstrom's Macroglobulinemia - On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D6795205-A4D9-0CD9-E034-0003BA12F5E7